L-alanine supplementation in late infantile glycogen storage disease type II

Olaf A. Bodamer; Dorothea Haas; Monique M. Hermans; Arnold J. Reuser; Georg F. Hoffmann

doi:10.1016/S0887-8994(02)00413-7

L-alanine supplementation in late infantile glycogen storage disease type II

Olaf A. Bodamer, Dorothea Haas, Monique M. Hermans, Arnold J. Reuser, Georg F. Hoffmann

Human Genetics

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.

Original language	English (US)
Pages (from-to)	145-146
Number of pages	2
Journal	Pediatric Neurology
Volume	27
Issue number	2
DOIs	https://doi.org/10.1016/S0887-8994(02)00413-7
State	Published - Aug 2002

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Neurology
Developmental Neuroscience
Clinical Neurology

Access to Document

10.1016/S0887-8994(02)00413-7

Fingerprint Dive into the research topics of 'L-alanine supplementation in late infantile glycogen storage disease type II'. Together they form a unique fingerprint.

Cite this

@article{347658d0e38b4a419021e05adf084765,

title = "L-alanine supplementation in late infantile glycogen storage disease type II",

abstract = "We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.",

author = "Bodamer, {Olaf A.} and Dorothea Haas and Hermans, {Monique M.} and Reuser, {Arnold J.} and Hoffmann, {Georg F.}",

year = "2002",

month = aug,

doi = "10.1016/S0887-8994(02)00413-7",

language = "English (US)",

volume = "27",

pages = "145--146",

journal = "Pediatric Neurology",

issn = "0887-8994",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - L-alanine supplementation in late infantile glycogen storage disease type II

AU - Bodamer, Olaf A.

AU - Haas, Dorothea

AU - Hermans, Monique M.

AU - Reuser, Arnold J.

AU - Hoffmann, Georg F.

PY - 2002/8

Y1 - 2002/8

N2 - We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.

AB - We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.

UR - http://www.scopus.com/inward/record.url?scp=0036696996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036696996&partnerID=8YFLogxK

U2 - 10.1016/S0887-8994(02)00413-7

DO - 10.1016/S0887-8994(02)00413-7

M3 - Article

C2 - 12213618

AN - SCOPUS:0036696996

VL - 27

SP - 145

EP - 146

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 2

ER -